Related Experiment Videos

Dangerous people with severe personality disorders

Maju Mathews, Manu Mathews, Kumar Budur

Psychiatric Services (Washington, D.C.)

|July 16, 2005

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension study.

Journal of neurodevelopmental disorders·2025

A proof-of-concept study of pitolisant for excessive daytime sleepiness in patients with Prader-Willi syndrome.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2025

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.

Neurology and therapy·2023

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality.

BMC psychiatry·2023

Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study.

Brain : a journal of neurology·2023

Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial.

The Lancet. Neurology·2022

See all related articles